Literature DB >> 12353812

Patterns of aneusomy for three chromosomes in individual cells from breast cancer tumors.

Tanja Fehm1, Larry Morrison, H Saboorian, Linda Hynan, Thomas Tucker, Jonathan Uhr.   

Abstract

Multi-color fluorescence in situ hybridization (FISH) can determine the changes in the copy numbers of several chromosomes simultaneously and can therefore be used to identify aneusomic patterns in individual cells. Aneusomic patterns may be useful for determining the malignant nature of rare epithelial cells in the blood of cancer patients. Touch preparations from 74 primary breast tumors were evaluated for aneusomy of chromosomes 1, 8 and 17 by tri-color-FISH. In the first part of the analysis, percentages of aneusomy for individual chromosomes and their combinations were determined. In the second part of the analysis, aneusomic patterns for these three chromosomes were analyzed in individual tumor cells and compared to aneusomic patterns observed in leukocytes and in individual cells from benign and normal breast tissue to determine aneusomic patterns indicative of malignancy. Ninety-two percentage of the primary breast carcinomas showed aneusomy for one or more enumerator probes. Comparison with benign breast tissue identified six aneusomic patterns in individual carcinoma cells indicative for malignancy by statistical analysis and not observed in leukocytes. Hence, certain patterns of aneusomy in individual cells involving chromosomes 1, 8 and 17 are indicative of malignancy in individual breast tumor cells and may be useful for determining malignancy of rare epithelial cells in the blood of breast cancer patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12353812     DOI: 10.1023/a:1019901010758

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  10 in total

1.  uPAR and HER2 Genes Are Usually Co-Amplified in Individual Breast Cancer Cells from Blood and Tissues.

Authors:  Jonathan Uhr
Journal:  Breast Care (Basel)       Date:  2008-10-16       Impact factor: 2.860

2.  Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer.

Authors:  Anna Zaczek; Aleksandra Markiewicz; Anna Supernat; Natalia Bednarz-Knoll; Burkhardt Brandt; Barbara Seroczyńska; Jarosław Skokowski; Jolanta Szade; Piotr Czapiewski; Wojciech Biernat; Marzena Wełnicka-Jaśkiewicz; Jacek Jassem
Journal:  Pathol Oncol Res       Date:  2012-03-18       Impact factor: 3.201

3.  Prognostic value of chromosome 1 and 8 copy number in invasive ductal breast carcinoma among Iranian women: an interphase FISH analysis.

Authors:  Farkhondeh Behjati; Morteza Atri; Hossein Najmabadi; Keramat Nouri; Mahdi Zamani; Parvin Mehdipour
Journal:  Pathol Oncol Res       Date:  2005-09-29       Impact factor: 3.201

4.  Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification.

Authors:  Matteo Brunelli; Alessia Nottegar; Giuseppe Bogina; Anna Caliò; Luca Cima; Albino Eccher; Caterina Vicentini; Lisa Marcolini; Aldo Scarpa; Serena Pedron; Eleonora Brunello; Sakari Knuutila; Anna Sapino; Caterina Marchiò; Emilio Bria; Annamaria Molino; Luisa Carbognin; Giampaolo Tortora; Bharat Jasani; Keith Miller; Ibrahim Merdol; Lucia Zanatta; Licia Laurino; Tiina Wirtanen; Giuseppe Zamboni; Marcella Marconi; Marco Chilosi; Erminia Manfrin; Guido Martignoni; Franco Bonetti
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

5.  HER-2, TOP2A and chromosome 17 alterations in breast cancer.

Authors:  Asli Rehber Beser; Sitki Tuzlali; Deniz Guzey; Semra Dolek Guler; Seniha Hacihanefioglu; Nejat Dalay
Journal:  Pathol Oncol Res       Date:  2007-10-07       Impact factor: 3.201

Review 6.  Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response.

Authors:  Monica M Reinholz; Amy K Bruzek; Daniel W Visscher; Wilma L Lingle; Matthew J Schroeder; Edith A Perez; Robert B Jenkins
Journal:  Lancet Oncol       Date:  2009-03       Impact factor: 41.316

Review 7.  Ductal approaches to assessment and management of women at high risk for developing breast cancer.

Authors:  Imogen Locke; Gillian Mitchell; Rosalind Eeles
Journal:  Breast Cancer Res       Date:  2004-01-26       Impact factor: 6.466

8.  Y-Box binding protein 1 expression in breast cancer and its correlation with hormone receptors and other prognostic markers.

Authors:  Taruna Bansal; Nadeem Tanveer; Usha Rani Singh; Sonal Sharma; Navneet Kaur
Journal:  J Lab Physicians       Date:  2018 Oct-Dec

9.  c-myc, not her-2/neu, can predict the prognosis of breast cancer patients: how novel, how accurate, and how significant?

Authors:  Fernando C Schmitt; Jorge S Reis-Filho
Journal:  Breast Cancer Res       Date:  2003-04-24       Impact factor: 6.466

10.  High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome.

Authors:  Klaus Jürgen Schmitz; Florian Grabellus; Rainer Callies; Friedrich Otterbach; Jeremias Wohlschlaeger; Bodo Levkau; Rainer Kimmig; Kurt Werner Schmid; Hideo Andreas Baba
Journal:  Breast Cancer Res       Date:  2005-01-07       Impact factor: 6.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.